Search

Despite ongoing debate over the reliability of PSA as a marker of disease progression, it remains the primary means of determining prostate cancer recurrence following local therapy as well as [...]

In 1996, AUA recognized cryoablation as a therapeutic option for prostate cancer and removed the "investigational" label from the procedure. Cryosurgery offers the appropriate candidate a minimally invasive, outpatient treatment [...]